Fundraising FoxPanorama Medicine
Philadelphia, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Panorama Medicine
Sign up to see every warm intro you have to Panorama Medicine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Panorama Medicine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
YX
Yi XingNamed on SEC filing
MZ
Mingfu ZhuNamed on SEC filing
JL
Jimmy LuNamed on SEC filing
Investors · 1
WI Harper GroupreportedSan Francisco · $5M – $15M
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 3 rounds · 2018–2021
▶$2MraisedJan 2021 · 3 investors · BiotechnologyRule 506(b)
▶$2MraisedJan 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yi XingDirector
- Yi-Yen ChenDirector
- Maxine GowenDirector
- Mingfu ZhuExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.1MraisedJun 2019 · 5 investors · BiotechnologyRule 506(b)
▶$2.1MraisedJun 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yi XingDirector
- Mingfu ZhuExecutive Officer, Director
- Jimmy LuDirector
- Offering amount
- $4.3M
- Amount sold
- $2.1M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$500KraisedJun 2019 · 3 investors · BiotechnologyRule 506(b)
▶$500KraisedJun 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yi XingDirector
- Mingfu ZhuExecutive Officer, Director
- Jimmy LuDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $333.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Panorama Medicine's investors?
- Panorama Medicine's investors include WI Harper Group.
- How much funding has Panorama Medicine raised?
- Panorama Medicine has disclosed $4.7M raised across 3 rounds.
- Where is Panorama Medicine headquartered?
- Panorama Medicine is headquartered in Philadelphia, US.